No Data
No Data
NRx Pharmaceuticals Regains Compliance With Nasdaq Minimum Market Value Of Listed Securities Requirement
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Regains Compliance With Nasdaq Minimum Market Value of Listed Securities Requirement
Express News | NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Announces the Appointment of Michael Taylor to Its Board of Directors and Appointment of Anita Nunes as Board Observer; MS. Nunes to Be Appointed Director of Hope Therapeutics, Inc.
Press Release: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces the Appointment of Michael Taylor to Its Board of Directors and Appointment of Anita Nunes as Board Observer; Ms. Nunes to Be Appointed Director of HOPE Therapeutics, Inc.
NRX Pharmaceuticals Announces Board Resignation and New Nominee
Press Release: HOPE Therapeutics(TM), Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Alert Investors to Sanjay Gupta/CNN Program on Ketamine, Featuring Kadima Neuropsychiatry Institute Founder Dr. David Feifel